I Bodrogi

Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council/European Organization for Research and Treatment of Cancer study.

R Sylvester, L Collette, L. Collette, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study.

P. Albers, M. Moore, I. Bodrogi, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Decreased toxicity schedule of suitinib in renal cell cancer: 2 weeks on/1 week off.

I Bodrogi, F Gyergyay, K Nagyványi, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.